Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Novavax Shares Rise 9% Upon Initiating Phase 1/2 COVID-19 Vaccine Clinical Trial

Novavax shares traded higher after the company reported it enrolled the first participants in its Phase 1 clinical study of NVX CoV2373. Novavax Inc. (NVAX:NASDAQ) , which focuses its efforts on developing next-generation vaccines to address infectious diseases, ye...
Streetwise Reports | May 27, 2020 |

Correction in Digital Marketing Sector Valuations Creates an Attractive Entry Point for Long-term In

(Click to read report.) Research Capital Corp. is – Initiating Coverage with a BUY Rating and Target Price of $2.20 (USD) on Logiq Inc. ( NEO: LGIQ , OTCQX: LGIQ , Forum ) Logiq’s Presence in Two Large and Growing Segments of Digital Marketing ...
Featured Submission | March 31, 2022 |

Alder BioPharmaceuticals Shares Surge 80% on Acquisition News

Shares of migraine treatment research firm Alder BioPharmaceuticals opened 84% higher today after the company announced that it has agreed to be acquired by H. Lundbeck for $1.95 billion. Early this morning, clinical-stage biopharmaceutical company Alder BioPharmaceu...
Streetwise Reports | September 17, 2019 |

ImmunoGen Shares Rise 25% on FY/19 Financial Results and Clinical Pipeline Updates

Shares of ImmunoGen Inc. reached a new 52-week intraday high price after the company announced FY/19 financial results and reported on recent developments including the completion of a $97.6 million capital raise in January 2020. Clinical-stage biotechnology...
Streetwise Reports | February 18, 2020 |

MediciNova Shares Rise 40% on Plans to Initiate COVID-19 ARDS Clinical Trial

Shares of MediciNova traded higher after the company reported that it plans to initiate a clinical study of MN-166 (ibudilast) for COVID-19 acute respiratory distress syndrome. Biopharmaceutical company MediciNova, Inc. yesterday announced that "it will ...
Streetwise Reports | April 13, 2020 |

Coverage Initiated on Company at 'Forefront of the Telehealth Revolution'

A review of CloudMD Software & Services and the reasons why it makes a compelling investment are provided in a Beacon Securities report. In a June 4 research note, analyst Gabriel Leung reported that Beacon Securities initiated coverage on CloudMD Software & Servi...
Streetwise Reports | June 9, 2020 |

Building a Better Covid-19 Antibody Test

ProMIS is harnessing its unique technology platform to develop a more error-free antibody test. Testing has been an Achilles heel of the coronavirus pandemic, but ProMIS Neurosciences Inc. (PMN:TSX; ARFXF:OTCQB) has partnered with Dr. Hans Frykman and the ...
Streetwise Reports | May 7, 2020 |

Hooray, Hooray: Ximen Mining is Back!

It was pretty quiet around Ximen Mining Corp. during the past corona weeks. Some may have thought, “Houston, we have a problem?” Far from it! On Friday after market close, the company announced its plans to go full throttle now – emphasizing in...
Stephan Bogner | May 19, 2020 |

99% Gold Recovery at Ximen‘s Kenville Gold Mine Project in Southern BC

Metallurgical Test Results Today, Ximen Mining Corp. announced the receipt of metallurgical test results for its Kenville Gold Mine Project near the city of Nelson in southern British Columbia, Canada. According to the press-release : “The Kenville material respo...
Stephan Bogner | May 22, 2020 |

Institutional Powerhouse: Ximen Mining engages Laurentian Bank Securities to act as ...

Institutional Powerhouse: Ximen Mining engages Laurentian Bank Securities to act as strategic financial advisors Letting the Kenville Gold Mine Plan Shine in New Brilliance Founded in 1846, Laurentian Bank is headquartered in Montreal and is one ...
Stephan Bogner | January 22, 2020 |
1 2 3 4 5 6 7 8 9 10 ...